Roivant Sciences Ltd.

ROIV ·Healthcare, Drug Manufacturers - General
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2023

Total Assets: $2.39B

Liabilities Breakdown FY2023

Total Liabilities: $782.0M